source
- Congressional biotech commission warns of China deal flowA bipartisan congressional panel that has steered much of the discourse on US biotech competitiveness is using its final weeks to highlight, and warn about, licensing deals with Chinese peers. The…Endpoints · 48m ago↗ source
- Sanofi's Infilbray wins first approval for neurological symptoms of GaucherSanofi won approval Wednesday for Infilbray, the first drug in the US to treat the neurological symptoms of a rare genetic disorder called Gaucher disease. Infilbray, also known as venglustat, cros…Endpoints · 1h ago↗ source
- Sanofi secures first FDA approval to treat neurological symptoms in rare metabolic diseaseSanofi’s Infilbray is designed to cross the blood-brain barrier, allowing the drug to prevent the toxic buildup of disease-causing lipids in the brain for patients with type 3 Gaucher disease.